223 related articles for article (PubMed ID: 8140075)
21. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
[TBL] [Abstract][Full Text] [Related]
22. [Pregnancy-related thrombocytosis].
Jønsson V; Bock JE; Mortensen TH; Staun M; Thorsen S
Ugeskr Laeger; 2002 Aug; 164(34):3946-9. PubMed ID: 12212474
[TBL] [Abstract][Full Text] [Related]
23. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.
Michiels JJ; Abels J; Steketee J; van Vliet HH; Vuzevski VD
Ann Intern Med; 1985 Apr; 102(4):466-71. PubMed ID: 3977194
[TBL] [Abstract][Full Text] [Related]
24. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
[TBL] [Abstract][Full Text] [Related]
25. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
26. Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent.
van Genderen PJ; Prins FJ; Michiels JJ; Schrör K
Br J Haematol; 1999 Mar; 104(3):438-41. PubMed ID: 10086775
[TBL] [Abstract][Full Text] [Related]
27. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
[TBL] [Abstract][Full Text] [Related]
28. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
[TBL] [Abstract][Full Text] [Related]
29. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases.
Buss DH; Stuart JJ; Lipscomb GE
Am J Hematol; 1985 Dec; 20(4):365-72. PubMed ID: 3865532
[TBL] [Abstract][Full Text] [Related]
30. Microvascular occlusive lesions in primary thrombocythaemia.
Singh AK; Wetherley-Mein G
Br J Haematol; 1977 Aug; 36(4):553-64. PubMed ID: 560852
[No Abstract] [Full Text] [Related]
31. Pseudohyperkalaemia in thrombocythaemia.
Wulkan RW; Michiels JJ
J Clin Chem Clin Biochem; 1990 Jul; 28(7):489-91. PubMed ID: 2230668
[TBL] [Abstract][Full Text] [Related]
32. [Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010].
Penka M; Schwarz J; Ovesná P; Hlusí A; Korístek Z; Doubek M; Dulícek P; Pospísilová D; Kissová J; Buliková A; Pavlík T;
Vnitr Lek; 2010 Jun; 56(6):503-12. PubMed ID: 20681462
[TBL] [Abstract][Full Text] [Related]
33. Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis.
Hur JW; Lee YY; Lee WS; Jun JB
Rheumatol Int; 2005 Nov; 26(1):83-5. PubMed ID: 15750823
[TBL] [Abstract][Full Text] [Related]
34. Essential thrombocythaemia.
Tobelem G
Baillieres Clin Haematol; 1989 Jul; 2(3):719-28. PubMed ID: 2505875
[TBL] [Abstract][Full Text] [Related]
35. Thrombocytosis, thrombocythaemia and iron deficiency in patients with polycythaemia vera.
Shaw D; Tudhope GR
Acta Haematol; 1979; 62(4):223-8. PubMed ID: 119415
[TBL] [Abstract][Full Text] [Related]
36. [Thrombotic events and significance of the IPSET thrombosis risk evaluation score in essential thrombocythaemia].
Pósfai É; Marton I; Nemes A; Borbényi Z
Orv Hetil; 2015 Apr; 156(14):558-63. PubMed ID: 25819149
[TBL] [Abstract][Full Text] [Related]
37. Recombinant interferon-alpha therapy of Philadelphia chromosome-negative myeloproliferative disorders with thrombocytosis.
Talpaz M; Kurzrock R; Kantarjian H; O'Brien S; Gutterman JU
Am J Med; 1989 May; 86(5):554-8. PubMed ID: 2712063
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous manifestations of essential thrombocythemia. Erythromelalgia, ischemic acrocyanosis, livedo racemosa].
Bauerschmitz J; Knop J
Hautarzt; 1995 Jul; 46(7):477-80. PubMed ID: 7672987
[TBL] [Abstract][Full Text] [Related]
39. Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist.
Kuipers RS; Kok L; Virmani R; Tefferi A
Neth Heart J; 2023 Oct; 31(10):371-378. PubMed ID: 36757576
[TBL] [Abstract][Full Text] [Related]
40. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
Walsh PN; Murphy S; Barry WE
Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
